These data demonstrate that aberrant expression altering of NT5DC3 and HKDC1 induced by intracellular glucose could be directly modulated by LF, underscoring the potential role of LF in colon cancer therapy. This evidence concerns the gene HKDC1 and malignant colon neoplasm.